Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | AKT2 |
| Upstream (Parents) |
|---|
| (<<) ADAM19 → AKT2 |
| (<<) APH1B → AKT2 |
| (<<) CCDC88A → AKT2 |
| (<<) CDK7 → AKT2 |
| (<<) COL13A1 → AKT2 |
| (<<) CSNK1A1 → AKT2 |
| (<<) CTGF → AKT2 |
| (<<) DUSP1 → AKT2 |
| (<<) FZD3 → AKT2 |
| (<<) GLI3 → AKT2 |
| (<<) HDAC4 → AKT2 |
| (<<) HIST1H3J → AKT2 |
| (<<) HMGA2 → AKT2 |
| (<<) HOXA3 → AKT2 |
| (<<) IL23A → AKT2 |
| (<<) MAP3K9 → AKT2 |
| (<<) NFKB2 → AKT2 |
| (<<) PLA2G3 → AKT2 |
| (<<) PRSS2 → AKT2 |
| (<<) RAB5A → AKT2 |
| (<<) SOCS5 → AKT2 |
| (<<) SOX2 → AKT2 |
| (<<) SOX3 → AKT2 |
| (<<) TCF4 → AKT2 |
| (<<) TGFA → AKT2 |
| Downstream (Children) |
|---|
| AKT2 → ACTC1 (>>) |
| AKT2 → ALK (>>) |
| AKT2 → ARID3B (>>) |
| AKT2 → AVP (>>) |
| AKT2 → CASP5 (>>) |
| AKT2 → DVL3 (>>) |
| AKT2 → FAM48A (>>) |
| AKT2 → FGF3 (>>) |
| AKT2 → FOXA2 (>>) |
| AKT2 → FZD1 (>>) |
| AKT2 → INE1 (>>) |
| AKT2 → MCL1 (>>) |
| AKT2 → MYH14 (>>) |
| AKT2 → N4BP3 (>>) |
| AKT2 → NFAT5 (>>) |
| AKT2 → PIK3R3 (>>) |
| AKT2 → PLK3 (>>) |
| AKT2 → RORA (>>) |
| AKT2 → RRAS2 (>>) |
| AKT2 → SLC26A1 (>>) |
| AKT2 → SMAD7 (>>) |
| AKT2 → SOX17 (>>) |
| AKT2 → SYNGR4 (>>) |
| AKT2 → T (>>) |
| AKT2 → TPM1 (>>) |
| AKT2 → ZNF750 (>>) |
